Navigation Links
Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
Date:5/28/2008

nformation, visit http://www.alfacell.com.

Safe Harbor

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, uncertainty whether the clinical trial results will allow the company to complete submission of a New Drug Application and if a New Drug Application submission is completed, uncertainty whether FDA will approve such application, uncertainties involved in transitioning from concept to product, uncertainties involving the ability of the company to finance research and development activities, potential challenges to or violations of patents, uncertainties regarding the outcome of clinical trials or differences of opinion in interpreting the results of clinical trials, the company's ability to secure necessary approvals from regulatory agencies, dependence upon third-party vendors, and other risks discussed in the company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Media Contact: Investor Contact:

David Schull or Wendy Lau Andreas Marathovouniotis

Russo Partners Russo Partners

212-845-4271 212-845-4235

David.Schull@russopartnersllc.com Andreas.Marathis@russopartnersllc.com


SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Alfacells ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment
2. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
3. Alfacell Reports Financial Results for First Quarter of Fiscal 2008
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
6. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
7. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
8. Dr. Peter Nash, Ph.D. Joins Mach One Corporation as Chief Scientist
9. Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
10. NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis
11. NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... June 24, 2015 ... addition of the "Future Horizons and Growth ... Supplier Shares and Country Forecasts" report to ... Strategies in the European Blood Banking Market 2015 ... to help current suppliers and potential market entrants ...
(Date:7/1/2015)... Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI ... disease and neurologic disorders, announced today the results of ... the Company,s lead compound. Results from the study show ... significantly inhibit the activation of inflammatory proteins in the ... compound in a Phase 1 clinical trial under a ...
(Date:7/1/2015)...  BioPharmX Corporation (NYSE MKT: BPMX) today announced the ... 3,636,364 shares of its common stock at a price ... granted the underwriters a 30-day option to purchase up ... public offering price. In addition, Korea Investment ... agreed to purchase 1,081,081 shares of common stock from ...
Breaking Medicine Technology:European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3
... March 22 Royal Philips Electronics ( PHG, ... medical alert service.  This integrated solution offers an added ... medical alert service with automatic fall detection capabilities. Lifeline ... can automatically call for help if a fall is ...
... WALTHAM, Mass. , March 22 Interleukin Genetics, Inc. ... of the NYSE Amex LLC (the "Exchange") has granted the Company an ... Company will remain listed up to June 23, 2010 , subject ... progress towards the Company,s plan to regain compliance. , ...
Cached Medicine Technology:Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 2Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 3Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 4Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 5Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 6NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 2NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 3
(Date:7/1/2015)... ... ... disorder in which the normally straight vertical line of the spine curves to one side. ... or an estimated 6 to 9 million people. While it is found in people of ... Most types of scoliosis are more common in girls than in boys. When a boy ...
(Date:7/1/2015)... ... July 01, 2015 , ... Bunion Bootie, the newest and ... two or more Bunion Booties directly from their website, http://www.BunionBootie.com can ... misaligned toes and its ultra thin properties allow for protection against rubbing footwear ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... solutions firm B. E. Smith, Tri-City Medical Center in Oceanside, Calif., ... a proven record of leading organization-wide compliance adaptation efforts and growing a focus ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Recovery Workforce Summit: 2015 PRA ... Stossel, editor of The Atlantic, as a keynote on June 2nd in Philadelphia, PA. ... telling his personal story added power and reach to the essential message, while opening ...
(Date:7/1/2015)... , ... July 01, 2015 ... ... the communities of southeast Alabama, southwest Georgia and the Florida Panhandle, the ... as its primary secure text messaging and clinical communications workflow solution provider. ...
Breaking Medicine News(10 mins):Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 2Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 4Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 5Health News:Southeast Alabama Community Health System Chooses TelmedIQ to Meet Secure Text Messaging Challenges for Healthcare 2
... French . , Intelligent wheelchairs that automatically ... specific colors on the walls and stairs in order ... falls, personal guides with special training for different types ... at Place Alexis Nihon due a new ambitious research ...
... Ga. Two emergency medicine physicians with wartime experience have ... Insurgents commonly aim just below a soldier,s body armor, where ... blood vessels, causing soldiers to bleed to death within minutes. ... tourniquet around it, so soldiers are getting shot in this ...
... Why do heavy coffee drinkers have a lower risk of ... the world that can lead to serious health problems? Scientists ... a report in ACS, Journal of Agricultural & Food ... that previous studies show that coffee drinkers are at a ...
... eating more dietary fiber to improve our health - that,s ... The team has looked at research conducted into dietary fiber ... suggests that to avoid initial problems, such as intestinal gas ... and to spread high-fiber foods out throughout the day, at ...
... Research into a ground-breaking treatment for bowel cancer at ... from Cancer Research UK. , Dr Sandra Van Schaeybroeck, ... from bowel cancer, has received a prestigious 688,000 Cancer ... which is one of only four fellowships awarded to ...
... Randy Dotinga HealthDay Reporter , TUESDAY, Jan. 10 ... does not seem to trigger declines in lung function that ... "Tobacco takes you down that road toward breathlessness, but ... Dr. Stefan Kertesz. But there were limits to the ...
Cached Medicine News:Health News:Emergency medicine physicians develop device to stop lethal bleeding in soldiers 2Health News:Emergency medicine physicians develop device to stop lethal bleeding in soldiers 3Health News:Increase dietary fiber, decrease disease 2Health News:Groundbreaking cancer research receives massive funding boost 2Health News:Occasional Pot Smoking Won't Harm Lungs: Study 2Health News:Occasional Pot Smoking Won't Harm Lungs: Study 3
Double-ended. Blades set at 45 and 90 degrees. Hexagonal handle....
3.5 mm blade. Round handle. Designated most popular model or size....
2 mm wide x 3 mm long, tapered handle. Angled 45 degrees. Round handle....
3 mm diameter roller blade, 15 mm from angle to tip. Round handle....
Medicine Products: